Vimarsana
Biggest News Aggregation in the World

Page 13 - Poster Section News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Poster Section. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Poster Section Today - Breaking & Trending Today

Kineta Unveils New Preclinical Data on its Anti-CD27 Agonist Lead Antibodies at AACR 2022 - Vimarsana News

Kineta Unveils New Preclinical Data on its Anti-CD27 Agonist Lead Antibodies at AACR 2022

/PRNewswire/ -- Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, announced today the...

Reaction Biology's Novel Approach to Oncology Drug Discovery - Vimarsana News

Reaction Biology's Novel Approach to Oncology Drug Discovery

Reaction Biology, an industry-leading provider of drug discovery services, today announced that twelve abstracts highlighting data from the Company's oncology drug discovery services platform will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2022, held April 8-13, 2022, in New Orleans, Louisiana.

Antengene Announces Publication of Five Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting - Vimarsana News

Antengene Announces Publication of Five Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting

/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering,...

Investegate |Syncona Limited Announcements | Syncona Limited: Anaveon announces initial clinical data - Vimarsana News

Investegate |Syncona Limited Announcements | Syncona Limited: Anaveon announces initial clinical data

Investegate announcements from Syncona Limited, Anaveon announces initial clinical data

GT Biopharma Presents Preclinical Data Demonstrating Novel - Vimarsana News

GT Biopharma Presents Preclinical Data Demonstrating Novel

- Ongoing experiments will evaluate the functionality and efficacy of the B7H3 TriKE in vivo- Future studies will also involve assessments of the B7H3...